|
|
||||||||
-Deficient Mice1

*
Medical and Research Services, Veterans Affairs Medical Center, and Renal Division, Department of Medicine, Emory University, Atlanta, GA 30033; and
Pathology and Laboratory Medicine, Veterans Affairs Medical Center and State University of New York, Buffalo, NY 14215
It is postulated that IFN-
confers susceptibility to
immunologically mediated tissue injury. To test this hypothesis, we
compared the intensity of accelerated anti-glomerular basement
membrane glomerulonephritis between wild-type (IFN-
+/+)
and IFN-
gene knockout (IFN-
-/-) mice. This disease
model is initiated by binding of heterologous (sheep)
anti-glomerular basement membrane Abs to the glomeruli of mice
preimmunized with sheep IgG. The secondary cellular and humoral immune
responses to the planted Ag then lead to albuminuria and glomerular
pathology. We found that IFN-
-/- mice or
IFN-
+/+ mice injected with IFN-
-neutralizing Ab
develop worse albuminuria and glomerular pathology than
IFN-
+/+ mice. The humoral response to sheep IgG (serum
mouse anti-sheep IgG titers and intraglomerular mouse IgG deposits)
was comparable in the IFN-
+/+ and
IFN-
-/- groups. In contrast, IFN-
-/-
mice mounted a stronger cellular immune response (cutaneous
delayed-type hypersensitivity reaction) to sheep IgG than
IFN-
+/+ mice. These findings provide evidence that
endogenous IFN-
has a protective role in immunologically mediated
glomerulonephritis initiated by foreign Ags.
This article has been cited by other articles:
![]() |
Y. Mori, T. Kodaka, T. Kato, E. M. Kanagawa, and O. Kanagawa Critical role of IFN-{gamma} in CFA-mediated protection of NOD mice from diabetes development Int. Immunol., November 1, 2009; 21(11): 1291 - 1299. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nakano, T. Higashi, R. Takagi, K. Hashimoto, Y. Tanaka, and S. Matsushita Dopamine released by dendritic cells polarizes Th2 differentiation Int. Immunol., June 1, 2009; 21(6): 645 - 654. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Scholz, V. Lukacs-Kornek, D. R. Engel, S. Specht, E. Kiss, F. Eitner, J. Floege, H.-J. Groene, and C. Kurts Renal Dendritic Cells Stimulate IL-10 Production and Attenuate Nephrotoxic Nephritis J. Am. Soc. Nephrol., March 1, 2008; 19(3): 527 - 537. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Kitching, A. L. Turner, T. Semple, M. Li, K. L. Edgtton, G. R. Wilson, J. R. Timoshanko, B. G. Hudson, and S. R. Holdsworth Experimental Autoimmune Anti-Glomerular Basement Membrane Glomerulonephritis: A Protective Role for IFN-{gamma} J. Am. Soc. Nephrol., July 1, 2004; 15(7): 1764 - 1774. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. G. Choudhury A Linear Signal Transduction Pathway Involving Phosphatidylinositol 3-Kinase, Protein Kinase C{epsilon}, and MAPK in Mesangial Cells Regulates Interferon-{gamma}-induced STAT1{alpha} Transcriptional Activation J. Biol. Chem., June 25, 2004; 279(26): 27399 - 27409. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ikezumi, R. C. Atkins, and D. J. Nikolic-Paterson Interferon-{gamma} Augments Acute Macrophage-Mediated Renal Injury Via a Glucocorticoid-Sensitive Mechanism J. Am. Soc. Nephrol., April 1, 2003; 14(4): 888 - 898. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kikawada, D. M. Lenda, and V. R. Kelley IL-12 Deficiency in MRL-Faslpr Mice Delays Nephritis and Intrarenal IFN-{gamma} Expression, and Diminishes Systemic Pathology J. Immunol., April 1, 2003; 170(7): 3915 - 3925. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Timoshanko, S. R. Holdsworth, A. R. Kitching, and P. G. Tipping IFN-{gamma} Production by Intrinsic Renal Cells and Bone Marrow-Derived Cells Is Required for Full Expression of Crescentic Glomerulonephritis in Mice J. Immunol., April 15, 2002; 168(8): 4135 - 4141. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Matthys, K. Vermeire, H. Heremans, and A. Billiau The protective effect of IFN-{gamma} in experimental autoimmune diseases: a central role of mycobacterial adjuvant-induced myelopoiesis J. Leukoc. Biol., October 1, 2000; 68(4): 447 - 454. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |